Comment
doi: 10.1016/S1470-2045(12)70010-4.
Epub 2012 Feb 21.
Anti-CD22 therapy in acute lymphoblastic leukaemia
Affiliations
- PMID: 22357139
- DOI: 10.1016/S1470-2045(12)70010-4
Item in Clipboard
Comment
Anti-CD22 therapy in acute lymphoblastic leukaemia
Lancet Oncol.
2012 Apr.
No abstract available
Comment on
-
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study.Lancet Oncol. 2012 Apr;13(4):403-11. doi: 10.1016/S1470-2045(11)70386-2. Epub 2012 Feb 21. Lancet Oncol. 2012. PMID: 22357140 Clinical Trial.
Similar articles
-
Inotuzumab ozogamicin, an anti-CD22-calecheamicin conjugate, for refractory and relapsed acute lymphocytic leukaemia: a phase 2 study.Lancet Oncol. 2012 Apr;13(4):403-11. doi: 10.1016/S1470-2045(11)70386-2. Epub 2012 Feb 21. Lancet Oncol. 2012. PMID: 22357140 Clinical Trial.
-
Inotuzumab ozogamicin in the treatment of acute lymphoblastic leukemia.Expert Rev Hematol. 2016;9(4):329-34. doi: 10.1586/17474086.2016.1143771. Epub 2016 Mar 22. Expert Rev Hematol. 2016. PMID: 26783163
-
Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: a Children's Oncology Group Pilot Study.J Clin Oncol. 2008 Aug 1;26(22):3756-62. doi: 10.1200/JCO.2007.15.3528. J Clin Oncol. 2008. PMID: 18669463 Free PMC article. Clinical Trial.
-
Inotuzumab Ozogamicin: First Global Approval.Drugs. 2017 Sep;77(14):1603-1610. doi: 10.1007/s40265-017-0802-5. Drugs. 2017. PMID: 28819740 Review.
-
Monoclonal antibody-based therapies in the treatment of acute lymphoblastic leukemia.Am Soc Clin Oncol Educ Book. 2013:294-9. doi: 10.14694/EdBook_AM.2013.33.294. Am Soc Clin Oncol Educ Book. 2013. PMID: 23714527 Review.
Cited by
-
Drug discovery and therapeutic delivery for the treatment of B and T cell tumors.Adv Drug Deliv Rev. 2017 May 15;114:285-300. doi: 10.1016/j.addr.2017.06.010. Epub 2017 Jun 15. Adv Drug Deliv Rev. 2017. PMID: 28625826 Free PMC article. Review.
-
The Influence of B Cell Depletion Therapy on Naturally Acquired Immunity to Streptococcus pneumoniae.Front Immunol. 2021 Jan 28;11:611661. doi: 10.3389/fimmu.2020.611661. eCollection 2020. Front Immunol. 2021. PMID: 33584691 Free PMC article.
-
Novel CD20 monoclonal antibodies for lymphoma therapy.J Hematol Oncol. 2012 Oct 11;5:64. doi: 10.1186/1756-8722-5-64. J Hematol Oncol. 2012. PMID: 23057966 Free PMC article. Review.
-
Maintained partial protection against Streptococcus pneumoniae despite B-cell depletion in mice vaccinated with a pneumococcal glycoconjugate vaccine.Clin Transl Immunology. 2021 Dec 28;11(1):e1366. doi: 10.1002/cti2.1366. eCollection 2022. Clin Transl Immunology. 2021. PMID: 35003749 Free PMC article.
-
Adenovirus carrying gene encoding Haliotis discus discus sialic acid binding lectin induces cancer cell apoptosis.Mar Drugs. 2014 Jun 30;12(7):3994-4004. doi: 10.3390/md12073994. Mar Drugs. 2014. PMID: 24983642 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
